24 Jan Nordion, Manufacturer of TheraSphere(R), to Host Educational Symposium at the 2013 Gastrointestinal Cancers Symposium
Agenda includes new HCC clinical data and an update on TheraSphere® Phase III clinical trials OTTAWA, Ontario–(BUSINESS WIRE)–Jan. 24, 2013– Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, announced today it is hosting…